Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA Monkeypox Vaccine in Adults
NCT06771479Phase 1Recruiting
- Sponsor
- Shanghai Institute of Biological Products
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors, Oncolytic Viruses
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of MVA-SIBP in mpox (6 arms), sponsored by Shanghai Institute of Biological Products. Primary endpoints: Immediate adverse events, Solicited Adverse Events and 4 more. Started Jan 2025; status: recruiting.
02
Drugs
MVA-SIBP
03
Conditions
mpox
Beyond the preview
Go deeper on NCT06771479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06771479.